Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?

Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?

In this review article we discuss the role of the memory T cells in multiple myeloma (MM) and how they may influence immune responses in patients that received immunomodulating drugs and check point therapy.

Bibliographic Details
Main Authors: Anne Marit Sponaas, Anders Waage, Esten N. Vandsemb, Kristine Misund, Magne Børset, Anders Sundan, Tobias Schmidt Slørdahl, Therese Standal
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Immunology
Subjects:
multiple myeloma
T cells
checkpoint therapy
immunomodulating drugs
virus
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.636375/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.636375/full

Similar Items